Identification and isolation of a membrane protein necessary for leukotriene production
- PMID: 2300172
- DOI: 10.1038/343278a0
Identification and isolation of a membrane protein necessary for leukotriene production
Abstract
Several inflammatory diseases, including asthma, arthritis and psoriasis are associated with the production of leukotrienes by neutrophils, mast cells and macrophages. The initial enzymatic step in the formation of leukotrienes is the oxidation of arachidonic acid by 5-lipoxygenase (5-LO) to leukotriene A4. Osteosarcoma cells transfected with 5-LO express active enzyme in broken cell preparations, but no leukotriene metabolites are produced by these cells when stimulated with the calcium ionophore A23187, indicating that an additional component is necessary for cellular 5-LO activity. A new class of indole leukotriene inhibitor has been described that inhibits the formation of cellular leukotrienes but has no direct inhibitory effect on soluble 5-LO activity. We have now used these potent agents to identify and isolate a novel membrane protein of relative molecular mass 18,000 which is necessary for cellular leukotriene synthesis.
Similar articles
-
Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.Inflamm Res. 1997 May;46(5):168-79. doi: 10.1007/s000110050163. Inflamm Res. 1997. PMID: 9197987
-
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.Mol Pharmacol. 1991 Jul;40(1):22-7. Mol Pharmacol. 1991. PMID: 1857337
-
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.Nature. 1990 Jan 18;343(6255):282-4. doi: 10.1038/343282a0. Nature. 1990. PMID: 2300173
-
Biosynthesis and metabolism of leukotrienes.Biochem J. 2007 Aug 1;405(3):379-95. doi: 10.1042/BJ20070289. Biochem J. 2007. PMID: 17623009 Review.
-
What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases.Trends Pharmacol Sci. 2008 Feb;29(2):72-8. doi: 10.1016/j.tips.2007.11.006. Epub 2008 Jan 9. Trends Pharmacol Sci. 2008. PMID: 18187210 Review.
Cited by
-
Recent advances in asthma.Postgrad Med J. 1992 Dec;68(806):942-53. doi: 10.1136/pgmj.68.806.942. Postgrad Med J. 1992. PMID: 1362982 Free PMC article. Review. No abstract available.
-
LTC4 synthase. Enzymology, biochemistry, and molecular characterization.Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):133-52. doi: 10.1007/BF02737601. Clin Rev Allergy Immunol. 1999. PMID: 10436863 Review.
-
The organization and consequences of eicosanoid signaling.J Clin Invest. 2003 Apr;111(8):1107-13. doi: 10.1172/JCI18338. J Clin Invest. 2003. PMID: 12697726 Free PMC article. Review. No abstract available.
-
Molecular cloning and expression of human leukotriene-C4 synthase.Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9745-9. doi: 10.1073/pnas.91.21.9745. Proc Natl Acad Sci U S A. 1994. PMID: 7937884 Free PMC article.
-
Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase.Agents Actions. 1994 Nov;43(1-2):64-8. doi: 10.1007/BF02005767. Agents Actions. 1994. PMID: 7741044 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases